Menu

As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
📰

As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments

US Top News and Analysis·about 4 hours ago
#B5nT2lB5
#cnbc#business#disease#sanofi#pompe
Long article (947 words) — no AI summary yet.
Reading 0:00
15s threshold

A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France, on June 15, 2022.

Benoit Tessier | Reuters

Two weeks ago, Monique Griffin got a troubling email.

The French drugmaker Sanofi told her that a shipping delay had interrupted supply of the drug that she relies on to manage her rare muscle-wasting disease. Her next infusion was canceled. Griffin, who is 51 and uses a wheelchair due to Pompe disease, fears what will happen if the shortage isn't resolved soon.

"You're basically letting the disease take over again," she said. "It's terrifying."

More than three months after initial reports of supply problems with treatments for Pompe disease, the disruption drags on, with more patients learning their infusions have been canceled. Sanofi said it has made progress restoring the supply to patients in some countries, but added that shipping delays could interrupt infusions for some U.S.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.